Market Tracker

05/24 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

14.90
Delayed Data
As of 3:59pm ET
 +0.55 / +3.83%
Today’s Change
12.21
Today|||52-Week Range
24.00
+13.74%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close14.35
Today’s open14.30
Day’s range14.30 - 14.95
Volume419,251
Average volume (3 months)762,865
Market cap$770.6M
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+19.69%
Earnings growth (next 5 years)+19.21%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.10-0.84%
BHVNBiohaven Pharmaceuti...-0.10-0.46%
LCILannett Company Inc-0.35-1.74%
OMEROmeros Corp+0.24+1.51%
Data as of 4:01pm ET, 05/24/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts